In 20 T2DM patients with an initial HbA1c of 11.7%, insulin treatment was associated with a 36% decrease in fibrinogen glycation, which corresponded to a 27% decreased rate of lateral aggregation and to 14% increased clot permeability [97]. This evidence concerns the gene INS and type 2 diabetes mellitus.